Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06161831 · ClinicalTrials.gov registry record · NA
HPV Vaccine Reminders - SEARCH II Study
A NA study of Human Papillomavirus Vaccination, sponsored by Columbia University.
- Active
- Registry status
- NA
- Development phase
- 396
- Enrollment target
- 2
- Study locations
NCT06161831 is a NA study of Human Papillomavirus Vaccination that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 396 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06161831, a NA study of Human Papillomavirus Vaccination, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 396 participants
- Enrollment target
- 2
- Study locations
Study Summary
This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.
Conditions Studied
Interventions
- BEHAVIORAL Text Message/automated phone reminder
Study Locations (2)
New York
- Columbia University Irving Medical Center - New York
Other
- Makerere University/Mulago Hospital - Kampala
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06161831
The ClinicalTrials.gov registry entry for NCT06161831 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 396 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Papillomavirus Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Text Message/automated phone reminder is the first listed.
NCT06161831 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.
Frequently Asked Questions
What is clinical trial NCT06161831 about?
NCT06161831 is a clinical study titled "HPV Vaccine Reminders - SEARCH II Study". This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text me...
What is the current status of trial NCT06161831?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 396 participants. The study started on 2024-04-22. Estimated completion is 2026-07-31.
What conditions does trial NCT06161831 study?
This clinical trial studies the following conditions: Human Papillomavirus Vaccination.
What interventions are being tested in trial NCT06161831?
The interventions under investigation include: Text Message/automated phone reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT06161831?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06161831 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.